YANKCOM Partnership’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
6,002
-209
-3% -$48.7K 0.55% 40
2026
Q1
$1.52M Sell
6,211
-784
-11% -$183K 0.62% 40
2025
Q4
$1.45M Sell
6,995
-59
-0.8% -$11.7K 0.62% 40
2025
Q3
$1.31M Buy
7,054
+12
+0.2% +$2.06K 0.59% 42
2025
Q2
$1.08M Buy
7,042
+58
+0.8% +$8.91K 0.53% 50
2025
Q1
$1.16M Buy
6,984
+605
+9% +$94.7K 0.64% 42
2024
Q4
$923K Buy
+6,379
New +$989K 0.49% 54

Other funds holding JNJ

YANKCOM Partnership's JNJ Position: Q2 2026 in Review

YANKCOM Partnership reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q2 2026, selling an estimated $48.7K and leaving 6,002 shares worth $1.52M. The position accounts for 0.55% of the portfolio, ranked #40.

YANKCOM Partnership first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 3,093 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • YANKCOM Partnership held 6,002 shares of Johnson & Johnson worth $1.52M as of Q2 2026.
  • YANKCOM Partnership sold 209 Johnson & Johnson shares in Q2 2026, an estimated $48.7K.
  • Johnson & Johnson made up 0.55% of YANKCOM Partnership's portfolio in Q2 2026, its #40 holding.
  • YANKCOM Partnership first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 3,093 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.